ABCL-367: Efficacy, Safety, and Patient-Reported Outcomes (PROs) of Treatments for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): A Systematic Literature Review (SLR).
- Resource Type
- Article
- Source
- Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS396-S396, 1p
- Subject
- Language
- ISSN
- 21522650